Symbols / CDIO
CDIO Chart
About
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 2.26M |
| Enterprise Value | -3.55M | Income | -6.55M | Sales | 15.78K |
| Book/sh | 4.61 | Cash/sh | 3.48 | Dividend Yield | — |
| Payout | 0.00% | Employees | 13 | IPO | — |
| P/E | — | Forward P/E | -4.96 | PEG | — |
| P/S | 143.47 | P/B | 0.27 | P/C | — |
| EV/EBITDA | 0.58 | EV/Sales | -224.91 | Quick Ratio | 15.98 |
| Current Ratio | 17.39 | Debt/Eq | 5.97 | LT Debt/Eq | — |
| EPS (ttm) | -11.86 | EPS next Y | -0.25 | EPS Growth | — |
| Revenue Growth | -56.60% | Earnings | 2026-03-12 | ROA | -61.58% |
| ROE | -110.70% | ROIC | — | Gross Margin | 100.00% |
| Oper. Margin | -599.51% | Profit Margin | 0.00% | Shs Outstand | 1.83M |
| Shs Float | 1.70M | Short Float | 8.49% | Short Ratio | 0.13 |
| Short Interest | — | 52W High | 20.34 | 52W Low | 0.97 |
| Beta | 2.87 | Avg Volume | 431.31K | Volume | 23.41K |
| Target Price | — | Recom | None | Prev Close | $1.27 |
| Price | $1.24 | Change | -2.36% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$1.19
Latest analyst target
3. DCF / Fair value
$-37.91
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.19
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-08-27 | reit | Benchmark | Speculative Buy → Speculative Buy | $2 |
| 2024-06-06 | main | Benchmark | Speculative Buy → Speculative Buy | $2 |
| 2024-04-19 | main | Benchmark | Speculative Buy → Speculative Buy | $1 |
| 2023-06-15 | reit | Benchmark | Speculative Buy → Speculative Buy | $8 |
| 2023-05-22 | init | Northland Capital Markets | — → Outperform | $8 |
| 2023-04-18 | reit | Benchmark | — → Speculative Buy | $8 |
- AI heart-disease test developer Cardio Diagnostics sets Feb. 18 investor call - Stock Titan ue, 17 Feb 2026 13
- Why CDIO stock is a must watch in 2025 - 2025 Fundamental Recap & Smart Investment Allocation Insights - mfd.ru Sun, 15 Feb 2026 04
- Cardio Diagnostics Holdings, Inc. (CDIO): A Bull Case Theory - Yahoo Finance Mon, 09 Jun 2025 07
- Resistance Check: Is CDIO stock undervalued right now - Market Growth Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn Mon, 16 Feb 2026 19
- CDIO Stock: Growth or Bubble? - timothysykes.com Wed, 07 Jan 2026 08
- Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split - Business Wire hu, 08 May 2025 07
- Cardio Diagnostics Regains Nasdaq Compliance After Reverse Stock Split - Nasdaq hu, 29 May 2025 07
- Cardio Diagnostics stock rises on strategic expansion into India - Investing.com Wed, 07 Jan 2026 08
- Why CDIO stock remains on buy lists - Exit Point & Fast Moving Stock Trade Plans - mfd.ru Sat, 14 Feb 2026 23
- New blood test uses AI to spot heart disease early, now coming to India - Stock Titan Wed, 07 Jan 2026 08
- Morning Market Movers: VTYX, CDIO, GLUE, EMAT See Big Swings - RTTNews Wed, 07 Jan 2026 08
- Cardio Diagnostics Holdings Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - simplywall.st Sat, 22 Mar 2025 07
- Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price - Business Wire hu, 29 May 2025 07
- Cardio Diagnostics Expands Global Footprint; Set To Launch PrecisionCHD In India; Stock Surges - Nasdaq Wed, 07 Jan 2026 08
- Why CDIO stock is a must watch in 2025 - 2025 Key Lessons & Verified Chart Pattern Signals - mfd.ru Sun, 15 Feb 2026 19
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 68965 | 20000 | — | Purchase at price 0.29 per share. | DOGAN MEESHANTHINI | Chief Technology Officer | — | 2024-09-06 00:00:00 | D |
| 1 | 68965 | 20000 | — | Purchase at price 0.29 per share. | DOGAN MEESHANTHINI | Chief Executive Officer | — | 2024-09-06 00:00:00 | D |
| 2 | 68965 | 20000 | — | Purchase at price 0.29 per share. | DOGAN MEESHANTHINI | Chief Executive Officer | — | 2024-09-06 00:00:00 | D |
| 3 | 68965 | 20000 | — | Purchase at price 0.29 per share. | DOGAN TIMUR | Chief Technology Officer | — | 2024-09-06 00:00:00 | D |
| 4 | 68965 | 20000 | — | Purchase at price 0.29 per share. | DOGAN TIMUR | Chief Technology Officer | — | 2024-09-06 00:00:00 | D |
| 5 | 34075 | 9763 | — | Purchase at price 0.28 - 0.29 per share. | PHILIBERT ROBERT | Officer and Director | — | 2024-09-06 00:00:00 | I |
| 6 | 8803 | 12500 | — | Conversion of Exercise of derivative security at price 1.42 per share. | LEVY ODED | Director | — | 2024-03-28 00:00:00 | D |
| 7 | 8803 | 12500 | — | Conversion of Exercise of derivative security at price 1.42 per share. | LAU STANLEY K | Director | — | 2024-03-28 00:00:00 | D |
| 8 | 8803 | 12500 | — | Conversion of Exercise of derivative security at price 1.42 per share. | INTRATER JAMES | Director | — | 2024-03-28 00:00:00 | D |
| 9 | 8803 | 12500 | — | Conversion of Exercise of derivative security at price 1.42 per share. | BURTON PAUL FREDERICK | Director | — | 2024-03-28 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -8.09M | -7.13M | -4.53M | -604.45K |
| TotalUnusualItems | 0.00 | 5.60M | -112.53K | 0.00 |
| TotalUnusualItemsExcludingGoodwill | 0.00 | 5.60M | -112.53K | 0.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | -8.38M | -8.38M | -4.66M | -620.45K |
| ReconciledDepreciation | 276.35K | 111.62K | 16.00K | 16.00K |
| EBITDA | -8.09M | -1.53M | -4.64M | -604.45K |
| EBIT | -8.36M | -1.64M | -4.66M | -620.45K |
| NetInterestIncome | -17.58K | -6.73M | 0.00 | |
| InterestExpense | 18.64K | 6.74M | 0.00 | |
| InterestIncome | 1.06K | 1.07K | 0.00 | |
| NormalizedIncome | -8.38M | -13.98M | -4.55M | -620.45K |
| NetIncomeFromContinuingAndDiscontinuedOperation | -8.38M | -8.38M | -4.66M | -620.45K |
| TotalExpenses | 8.40M | 7.26M | 4.55M | 621.35K |
| TotalOperatingIncomeAsReported | -8.37M | -7.24M | -4.55M | -620.45K |
| DilutedAverageShares | 896.42K | 422.84K | 102.92K | 317.16K |
| BasicAverageShares | 896.42K | 422.84K | 102.92K | 317.16K |
| DilutedEPS | -9.30 | -19.80 | -45.30 | -1.96 |
| BasicEPS | -9.30 | -19.80 | -45.30 | -1.96 |
| DilutedNIAvailtoComStockholders | -8.38M | -8.38M | -4.66M | -620.45K |
| NetIncomeCommonStockholders | -8.38M | -8.38M | -4.66M | -620.45K |
| NetIncome | -8.38M | -8.38M | -4.66M | -620.45K |
| NetIncomeIncludingNoncontrollingInterests | -8.38M | -8.38M | -4.66M | -620.45K |
| NetIncomeContinuousOperations | -8.38M | -8.38M | -4.66M | -620.45K |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -8.38M | -8.38M | -4.66M | -620.45K |
| OtherIncomeExpense | 5.60M | -112.53K | ||
| SpecialIncomeCharges | 0.00 | 193.35K | -112.53K | 0.00 |
| OtherSpecialCharges | -193.35K | |||
| RestructuringAndMergernAcquisition | 0.00 | 112.53K | 0.00 | |
| GainOnSaleOfSecurity | 5.41M | |||
| NetNonOperatingInterestIncomeExpense | -17.58K | -6.73M | 0.00 | |
| InterestExpenseNonOperating | 18.64K | 6.74M | 0.00 | |
| InterestIncomeNonOperating | 1.06K | 1.07K | 0.00 | |
| OperatingIncome | -8.37M | -7.24M | -4.55M | -620.45K |
| OperatingExpense | 8.40M | 7.26M | 4.55M | 621.35K |
| DepreciationAmortizationDepletionIncomeStatement | 19.74K | 19.18K | 16.00K | 16.00K |
| DepreciationAndAmortizationInIncomeStatement | 19.74K | 19.18K | 16.00K | 16.00K |
| Amortization | 19.74K | 19.18K | 16.00K | 16.00K |
| AmortizationOfIntangiblesIncomeStatement | 19.74K | 19.18K | 16.00K | 16.00K |
| ResearchAndDevelopment | 29.12K | 145.18K | 40.45K | 31.47K |
| SellingGeneralAndAdministration | 8.35M | 7.10M | 4.49M | 573.88K |
| SellingAndMarketingExpense | 182.45K | 158.51K | 92.70K | 103.32K |
| GeneralAndAdministrativeExpense | 8.17M | 6.94M | 4.40M | 470.56K |
| OtherGandA | 8.17M | 6.94M | 4.40M | 470.56K |
| TotalRevenue | 34.89K | 17.07K | 950.00 | 901.00 |
| OperatingRevenue | 34.89K | 17.07K | 950.00 | 901.00 |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 1.53M | 684.68K | 317.16K | 317.16K |
| ShareIssued | 1.53M | 684.68K | 317.16K | 317.16K |
| TotalDebt | 663.10K | 887.03K | 0.00 | |
| TangibleBookValue | 8.85M | 2.42M | 3.94M | 769.50K |
| InvestedCapital | 9.56M | 2.96M | 4.30M | 1.07M |
| WorkingCapital | 8.16M | 1.92M | 3.94M | 769.62K |
| NetTangibleAssets | 8.85M | 2.42M | 3.94M | 769.50K |
| CapitalLeaseObligations | 663.10K | 887.03K | 0.00 | |
| CommonStockEquity | 9.56M | 2.96M | 4.30M | 1.07M |
| TotalCapitalization | 9.56M | 2.96M | 4.30M | 1.07M |
| TotalEquityGrossMinorityInterest | 9.56M | 2.96M | 4.30M | 1.07M |
| StockholdersEquity | 9.56M | 2.96M | 4.30M | 1.07M |
| RetainedEarnings | -22.75M | -14.37M | -5.99M | -1.33M |
| AdditionalPaidInCapital | 32.31M | 17.33M | 10.29M | 2.40M |
| CapitalStock | 459.00 | 205.00 | 95.00 | 0.00 |
| CommonStock | 459.00 | 205.00 | 95.00 | 0.00 |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 1.06M | 1.50M | 1.95M | 34.01K |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 425.83K | 663.10K | 0.00 | 123.00 |
| OtherNonCurrentLiabilities | 123.00 | |||
| TradeandOtherPayablesNonCurrent | 1.10M | 33.88K | ||
| LongTermDebtAndCapitalLeaseObligation | 425.83K | 663.10K | 0.00 | |
| LongTermCapitalLeaseObligation | 425.83K | 663.10K | 0.00 | |
| CurrentLiabilities | 631.70K | 841.14K | 1.95M | 33.88K |
| CurrentDebtAndCapitalLeaseObligation | 237.27K | 223.93K | ||
| CurrentCapitalLeaseObligation | 237.27K | 223.93K | 0.00 | |
| PayablesAndAccruedExpenses | 394.43K | 617.21K | 1.95M | 33.88K |
| Payables | 394.43K | 617.21K | 1.95M | 33.88K |
| OtherPayable | 306.76K | 374.00K | 849.03K | |
| AccountsPayable | 87.66K | 243.21K | 1.10M | 33.88K |
| TotalAssets | 10.62M | 4.46M | 6.25M | 1.10M |
| TotalNonCurrentAssets | 1.82M | 1.70M | 363.59K | 298.49K |
| NonCurrentPrepaidAssets | 12.85K | 12.85K | 4.95K | 0.00 |
| GoodwillAndOtherIntangibleAssets | 706.42K | 536.74K | 358.64K | 298.49K |
| OtherIntangibleAssets | 706.42K | 536.74K | 358.64K | 298.49K |
| NetPPE | 1.11M | 1.15M | 0.00 | |
| AccumulatedDepreciation | -117.57K | -3.79K | 0.00 | |
| GrossPPE | 1.22M | 1.15M | 0.00 | |
| Leases | 502.15K | 482.17K | 0.00 | |
| OtherProperties | 602.82K | 575.23K | ||
| MachineryFurnitureEquipment | 117.85K | 93.49K | 0.00 | |
| Properties | 0.00 | 0.00 | 0.00 | |
| CurrentAssets | 8.79M | 2.77M | 5.89M | 803.51K |
| OtherCurrentAssets | 944.68K | 1.48M | 1.77M | 39.84K |
| PrepaidAssets | 0.00 | 250.00K | ||
| Receivables | 18.61K | 4.96K | 0.00 | 901.00 |
| AccountsReceivable | 18.61K | 4.96K | 0.00 | 901.00 |
| CashCashEquivalentsAndShortTermInvestments | 7.83M | 1.28M | 4.12M | 512.77K |
| CashAndCashEquivalents | 7.83M | 1.28M | 4.12M | 512.77K |
| CashFinancial | 7.83M | 1.28M | 4.12M | 512.77K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -5.40M | -6.47M | -5.17M | -699.32K |
| IssuanceOfDebt | 0.00 | 4.50M | 0.00 | |
| IssuanceOfCapitalStock | 12.55M | 0.00 | 11.99M | 1.12M |
| CapitalExpenditure | -404.19K | -794.29K | -76.15K | -114.03K |
| InterestPaidSupplementalData | 18.64K | 30.49K | 5.83K | 0.00 |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | ||
| EndCashPosition | 7.83M | 1.28M | 4.12M | 512.77K |
| BeginningCashPosition | 1.28M | 4.12M | 512.77K | 237.09K |
| ChangesInCash | 6.54M | -2.83M | 3.60M | 275.68K |
| FinancingCashFlow | 11.94M | 3.63M | 9.06M | 1.23M |
| CashFlowFromContinuingFinancingActivities | 11.94M | 3.63M | 9.06M | 1.23M |
| NetOtherFinancingCharges | -605.69K | -1.26M | -2.92M | 105.00K |
| ProceedsFromStockOptionExercised | 0.00 | 390.00K | 0.00 | |
| NetCommonStockIssuance | 12.55M | 0.00 | 11.99M | 1.12M |
| CommonStockIssuance | 12.55M | 0.00 | 11.99M | 1.12M |
| NetIssuancePaymentsOfDebt | 0.00 | 4.50M | 0.00 | |
| NetLongTermDebtIssuance | 0.00 | 4.50M | 0.00 | |
| LongTermDebtIssuance | 0.00 | 4.50M | 0.00 | |
| InvestingCashFlow | -404.19K | -794.29K | -368.00K | -364.03K |
| CashFlowFromContinuingInvestingActivities | -404.19K | -794.29K | -368.00K | -364.03K |
| NetOtherInvestingChanges | -21.35K | -433.33K | ||
| NetBusinessPurchaseAndSale | 0.00 | 141.49K | -250.00K | |
| SaleOfBusiness | 0.00 | 141.49K | 0.00 | |
| PurchaseOfBusiness | 0.00 | -250.00K | ||
| NetIntangiblesPurchaseAndSale | -189.43K | -197.28K | -76.15K | -114.03K |
| PurchaseOfIntangibles | -189.43K | -197.28K | -76.15K | -114.03K |
| NetPPEPurchaseAndSale | -214.76K | -597.01K | 0.00 | |
| PurchaseOfPPE | -214.76K | -597.01K | 0.00 | |
| OperatingCashFlow | -4.99M | -5.67M | -5.09M | -585.29K |
| CashFlowFromContinuingOperatingActivities | -4.99M | -5.67M | -5.09M | -585.29K |
| ChangeInWorkingCapital | 522.84K | 208.81K | -558.52K | -37.56K |
| ChangeInOtherCurrentLiabilities | -223.93K | 244.50K | 0.00 | |
| ChangeInPayablesAndAccruedExpense | -155.55K | -781.50K | 136.35K | -5.65K |
| ChangeInPrepaidAssets | 915.97K | 750.77K | -695.77K | -31.01K |
| ChangeInReceivables | -13.65K | -4.96K | 901.00 | -901.00 |
| ChangesInAccountReceivables | -13.65K | -4.96K | 901.00 | -901.00 |
| OtherNonCashItems | 6.70M | 112.53K | -3.28K | |
| StockBasedCompensation | 2.59M | 1.28M | 0.00 | 60.00K |
| DepreciationAmortizationDepletion | 276.35K | 111.62K | 16.00K | 16.00K |
| DepreciationAndAmortization | 276.35K | 111.62K | 16.00K | 16.00K |
| AmortizationCashFlow | 162.57K | 107.83K | 16.00K | 16.00K |
| AmortizationOfIntangibles | 162.57K | 107.83K | 16.00K | 16.00K |
| Depreciation | 113.78K | 3.79K | 0.00 | |
| OperatingGainsLosses | -5.60M | |||
| GainLossOnInvestmentSecurities | -5.41M | |||
| NetIncomeFromContinuingOperations | -8.38M | -8.38M | -4.66M | -620.45K |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for CDIO
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|